ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2020 American Transplant Congress

    Cigarette Smoking and Long-Term Renal Function and Cardiovascular Disease in Living Kidney Donors

    S. Getsin1, M. Waldram1, Y. Yu1, D. Brennan1, F. Al Ammary1, J. Garonzik-Wang1, M. Henderson1, J. Locke2, R. Reed2, K. Lentine3, D. Segev1, A. Massie1

    1Johns Hopkins School of Medicine, Baltimore, MD, 2University of Alabama at Birmingham School of Medicine, Birmingham, AL, 3Saint Louis University School of Medicine, St. Louis, MO

    *Purpose: Since cigarette smoking is a major risk factor for kidney and cardiovascular disease in the general population, many programs advise living kidney donor candidates…
  • 2020 American Transplant Congress

    Delayed Introduction of Mammalian Inhibitors of Rapamycin (mTOR) Post Kidney Transplantation Might Avoid the Chronic Nephrotoxicity of Calcineurin Inhibitors. Herein We Are Reporting an Eight-Years Single Center Experience of mTOR-Based Immunosuppression Regimen in Comparison with Cyclosporin-Based Regimen

    W. A. Hassan1, H. M. Tawfik2

    1Medicine-Nephrology, University of Tennessee Health Science Center, Memphis, TN, 2Medicine-Nephrology, Minia Nephrology Hospital, Minia University, Minia, Egypt

    *Purpose: Delayed introduction of mTOR inhibitors post kidney transplantation might avoid the chronic nephrotoxicity of CNI: eight-years single center experience.*Methods: This is a retrospective analysis…
  • 2020 American Transplant Congress

    Converting from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide for Treatment of Patients with Hepatitis B Following Liver Transplantation

    C. Cheng

    Department of General Surgery, Chang Gung Memorial Hospital at Linkou, Kwei-Shan Township, Taoyuan, Taiwan

    *Purpose: Taiwan has a high prevalence of hepatitis B (HBV) and HBV related end-stages liver diseases are the leading causes of liver transplantation (LT). Tenofovir…
  • 2020 American Transplant Congress

    Re-Transplantation Outcomes in the United States Before and after DAA-Introduction

    T. Ivanics, M. Rizzari, A. Al-Kurd, T. Kitajima, A. Elsabbagh, K. Collins, A. Yoshida, M. Abouljoud, S. Nagai

    Surgery, Henry Ford Hospital, Detroit, MI

    *Purpose: The success of direct-acting antiviral (DAA) therapy has led to the widespread treatment of HCV and near-universal cure for chronically infected patients and improved…
  • 2020 American Transplant Congress

    Atrial Fibrillation Predicts Inferior Survival in Liver Transplant Recipients of Advanced Age in a Large Multicenter U.S. Cohort

    M. German1, A. Hristov1, A. Lee1, F. Osman1, A. Kwong2, D. Devuni3, C. Wang4, J. Boike5, J. Jo5, L. VanWagner5, M. Serper6, R. Sharma7, E. Verna7, J. Shor3, A. Koteish8, G. Sehmbey9, A. Seetharam9, N. John2, Y. Patel10, M. Kappus10, T. Couri11, S. Paul11, R. Salgia12, Q. Nhu13, C. Frenette13, J. Lai4, A. Goel2, E. Spengler1

    1U of Wisconsin, Madison, WI, 2Stanford, Palo Alto, CA, 3U of Massachusetts, Worcester, MA, 4U of California, San Francisco, CA, 5Northwestern, Chicago, IL, 6U of Pennsylvania, Philadelphia, PA, 7Columbia, New York, NY, 8Florida Hospital, Orlando, FL, 9U of Arizona, Phoenix, AZ, 10Duke, Durham, NC, 11U of Chicago, Chicago, IL, 12Henry Ford Hospital, Detroit, MI, 13Scripps, San Diego, CA

    *Purpose: More liver transplants (LT) are being performed in patients >65 years (y) - a population with higher rates of cardiovascular (CV) disease. It is…
  • 2020 American Transplant Congress

    Risk Factors of Invasive Fungal Infections in Liver Transplantation: Systematic Review and Meta-Analysis

    P. Phoompoung1, S. Herrera2, A. Perez Cortes Villalobos1, F. Foroutan1, A. Orchanian-Cheff1, S. Husain1

    1University Health Network, Toronto, ON, Canada, 2Hospital Universitario Ramón y Cajal, Universidad de Alcalá (IRYCIS), Madrid, Spain

    *Purpose: Invasive fungal infection (IFI) remains one of the most common infectious complications after solid organ transplantation. Liver transplant recipients (LTRs) have a higher mortality…
  • 2020 American Transplant Congress

    Clinical Correlation of Results of s CD4/CD8 Cytomegalovirus Cell Mediated Immunity Test with Incidence of Cytomegalovirus Infection

    M. Jorgenson1, M. Hillis1, C. Saddler2, J. Smith2, D. Mandelbrot2

    1UW Health, Madison, WI, 2UWMF, Madison, WI

    *Purpose: The purpose of this study was to evaluate the predictive potential of a CD4/CD8 flow cytometric cell mediated immunity (CMI) assay for the development…
  • 2020 American Transplant Congress

    Epstein-Barr Virus (EBV)+ Post-Transplant Lymphoproliferative Disorder (PTLD) is Associated with Tumor CCL3/CCL4 Expression and an Increase in Tumor-Infiltrating Monocytes

    J. Toh1, F. Vallania1, W. A. Haynes1, G. Bhagat2, F. E. Craig3, S. H. Swerdlow4, T. Tousseyn5, S. M. Krams1, P. Khatri1, O. M. Martinez1

    1Stanford University School of Medicine, Stanford, CA, 2Columbia University Medical Center, New York City, NY, 3Mayo Clinic College of Medicine, Phoenix, AZ, 4University of Pittsburgh School of Medicine, Pittsburgh, PA, 5Katholieke Universiteit Leuven, Leuven, Belgium

    *Purpose: PTLD is a serious post-transplant complication that encompasses a spectrum of abnormal lymphoproliferations, including B cell lymphoma-type PTLDs. Although many are EBV-driven, a significant…
  • 2020 American Transplant Congress

    Frequency and Main Diagnoses of Hospitalizations in Patients after Kidney Transplantation

    W. Duettmann-Rehnolt, P. Glander, P. Bach, F. Halleck, V. Graf, L. Lehner, M. Duerr, M. Mayrdorfer, K. Budde, M. Naik

    Nephrology, Charité-Universitätsmedizin Berlin, Berlin, Germany

    *Purpose: Kidney transplant recipients (KTR) suffer many complications and are hospitalized frequently. Specific reasons for hospital admission with detailed information are scarce.*Methods: We retrieved data…
  • 2020 American Transplant Congress

    Access to and Survival Benefit of Kidney Transplantation in Patients with Sickle Cell Disease-Associated End-Stage Renal Disease in the United States

    S. Bae, M. Johnson, A. Massie, X. Luo, C. Haywood Jr., S. Lanzkron, M. Grams, D. Segev, T. Purnell

    Johns Hopkins School of Medicine, Baltimore, MD

    *Purpose: Patients with end-stage renal disease due to sickle cell disease (SCD-ESRD) have high mortality, which might be reduced by kidney transplantation (KT). However, whether…
  • « Previous Page
  • 1
  • …
  • 92
  • 93
  • 94
  • 95
  • 96
  • …
  • 223
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences